The canine papillomavirus E5 protein signals from the endoplasmic reticulum

Journal of Virology

Volumn 83, Issue 24, 2009, Pages 12833-12841

  Condjella, Rachel ^a   Liu, Xuefeng ^a   Suprynowicz, Frank ^a   Yuan, Hang ^a   Sudarshan, Sawali ^a   Dai, Yuhai ^a   Schlegel, Richard ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CANINE PAPILLOMAVIRUS PROTEIN E5; MESSENGER RNA; POLYPEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CANINE PAPILLOMAVIRUS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HYDROPHOBICITY; KERATINOCYTE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA SPLICING; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; DOGS; ENDOPLASMIC RETICULUM; KERATINOCYTES; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PAPILLOMAVIRIDAE; RNA SPLICING; TRANSCRIPTION FACTORS; UNFOLDED PROTEIN RESPONSE; VIRAL PROTEINS;

CANIS FAMILIARIS; PAPILLOMAVIRIDAE;

EID: 72849142353     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01003-09     Document Type: Article

References (61)

1. Adam, J. L., M. W. Briggs, and D. J. McCance. 2000. A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems. Virology 272:315-325.
2. Ashrafi, G. H., M. Haghshenas, B. Marchetti, and M. S. Campo. 2006. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int. J. Cancer 119:2105-2112.
3. Ashrafi, G. H., M. R. Haghshenas, B. Marchetti, P. M. O'Brien, and M. S. Campo. 2005. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int. J. Cancer 113:276-283.
4. Ashrafi, G. H., E. Tsirimonaki, B. Marchetti, P. M. O'Brien, G. J. Sibbet, L. Andrew, and M. S. Campo. 2002. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21:248-259. (Pubitemid 34102133)
5. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seideman, J. A. Smith, and K. Struhl. 1994. Current protocols in molecular biology. Wiley, New York, NY.
6. Baege, A. C., A. Berger, R. Schlegel, and T. Veldman. 2002. Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. Am. J. Pathol. 160:1251-1257.
7. Bickel, P. E., P. E. Scherer, J. E. Schnitzer, P. Oh, M. P. Lisanti, and H. F. Lodish. 1997. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem. 272:13793-13802.
8. Brewer, J. W., and J. A. Diehl. 2000. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc. Natl. Acad. Sci. USA 97:12625-12630.
9. Brewer, J. W., L. M. Hendershot, C. J. Sherr, and J. A. Diehl. 1999. Mammalian unfolded protein response inhibits cyclin D1 translation and cellcycle progression. Proc. Natl. Acad. Sci. USA 96:8505-8510.
10. Brown, D. A., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:111-136.
11. Burkhardt, A., M. Willingham, C. Gay, K. T. Jeang, and R. Schlegel. 1989. The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology 170:334-339. (Pubitemid 19133996)
12. Calfon, M., H. Zeng, F. Urano, J. H. Till, S. R. Hubbard, H. P. Harding, S. G. Clark, and D. Ron. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415:92-96. (Pubitemid 34062456)
13. Reference deleted.
14. Chamberlain, L. H. 2004. Detergents as tools for the purification and classification of lipid rafts. FEBS Lett. 559:1-5.
15. Collier, B., L. Goobar-Larsson, M. Sokolowski, and S. Schwartz. 1998. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273:22648-22656.
16. Conrad, M., V. J. Bubb, and R. Schlegel. 1993. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67:6170-6178. (Pubitemid 23277529)
17. Crusius, K., E. Auvinen, and A. Alonso. 1997. Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene 15:1437-1444. (Pubitemid 27437833)
18. Disbrow, G. L., J. A. Hanover, and R. Schlegel. 2005. Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J. Virol. 79:5839-5846.
19. Disbrow, G. L., I. Sunitha, C. C. Baker, J. Hanover, and R. Schlegel. 2003. Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology 311:105-114.
20. Drummond-Barbosa, D. A., R. R. Vaillancourt, A. Kazlauskas, and D. Di-Maio. 1995. Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Mol. Cell. Biol. 15:2570-2581.
21. Genther Williams, S. M., G. L. Disbrow, R. Schlegel, D. Lee, D. W. Threadgill, and P. F. Lambert. 2005. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res. 65:6534-6542.
22. Goldstein, D. J., and R. Schlegel. 1990. The E5 oncoprotein of bovine papillomavirus binds to a 16 kd cellular protein. EMBO J. 9:137-145.
23. Henkler, F., J. Hoare, N. Waseem, R. D. Goldin, M. J. McGarvey, R. Koshy, and I. A. King. 2001. Intracellular localization of the hepatitis B virus HBx protein. J. Gen. Virol. 82:871-882.
24. Hwang, E. S., T. Nottoli, and D. Dimaio. 1995. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology 211:227-233.
25. Krawczyk, E., J. A. Hanover, R. Schlegel, and F. A. Suprynowicz. 2008. Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein. Biochem. Biophys. Res. Commun. 371:684-688.
26. Krawczyk, E., F. A. Suprynowicz, X. Liu, Y. Dai, D. P. Hartmann, J. Hanover, and R. Schlegel. 2008. Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am. J. Pathol. 173:682-688.
27. Lazarczyk, M., C. Pons, J. A. Mendoza, P. Cassonnet, Y. Jacob, and M. Favre. 2008. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med. 205:35-42.
28. Lee, K., W. Tirasophon, X. Shen, M. Michalak, R. Prywes, T. Okada, H. Yoshida, K. Mori, and R. J. Kaufman. 2002. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 16:452-466. (Pubitemid 34165102)
29. Li, B., B. Gao, L. Ye, X. Han, W. Wang, L. Kong, X. Fang, Y. Zeng, H. Zheng, S. Li, and Z. Wu. 2007. Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response. Virus Res. 124:44-49.
30. Lowe, M., N. K. Gonatas, and G. Warren. 2000. The mitotic phosphorylation cycle of the cis-Golgi matrix protein GM130. J. Cell Biol. 149:341-356.
31. Medigeshi, G. R., A. M. Lancaster, A. J. Hirsch, T. Briese, W. I. Lipkin, V. Defilippis, K. Fruh, P. W. Mason, J. Nikolich-Zugich, and J. A. Nelson. 2007. West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J. Virol. 81:10849-10860.
32. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-982, 984-986, 989-990.
33. Miller, S., S. Kastner, J. Krijnse-Locker, S. Buhler, and R. Bartenschlager. 2007. The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J. Biol. Chem. 282:8873-8882.
34. Reference deleted.
35. Nonnenmacher, M., J. Salmon, Y. Jacob, G. Orth, and F. Breitburd. 2006. Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis. J. Virol. 80:4890-4900.
36. O'Brien, P. M., and M. Saveria Campo. 2002. Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res. 88:103-117.
37. Oda, T., S. Watanabe, S. Hanakawa, and N. Hosogi. 1981. Complete in vitro replication of SV40 DNA and chromatin in saponin-treated permeable cells. Acta Med. Okayama 35:149-154. (Pubitemid 11063471)
38. Oda, T., S. Watanabe, S. Hanakawa, and T. Nakamura. 1980. Complete in vitro DNA replication of SV40 chromatin in digitonin-treated permeable cells. Acta Med. Okayama 34:409-413. (Pubitemid 11144397)
39. Olcese, V. A., Y. Chen, R. Schlegel, and H. Yuan. 2004. Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope. BMC Microbiol. 4:29.
40. Regan, J. A., and L. A. Laimins. 2008. Bap31 is a novel target of the human papillomavirus E5 protein. J. Virol. 82:10042-10051.
41. Schroder, M., and R. J. Kaufman. 2005. ER stress and the unfolded protein response. Mutat. Res. 569:29-63.
42. Sparkowski, J., J. Anders, and R. Schlegel. 1994. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. J. Virol. 68:6120-6123. (Pubitemid 24258637)
43. Staebler, A., J. H. Pierce, S. Brazinski, M. A. Heidaran, W. Li, R. Schlegel, and D. J. Goldstein. 1995. Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein. J. Virol. 69:6507-6517.
44. Stoppler, H., D. P. Hartmann, L. Sherman, and R. Schlegel. 1997. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J. Biol. Chem. 272:13332-13337.
45. Straight, S. W., P. M. Hinkle, R. J. Jewers, and D. J. McCance. 1993. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67:4521-4532.
46. Suprynowicz, F. A., Campo, M. S., and Schlegel, R. 2006. Chapter 8: biological activities of papillomavirus E5 proteins, p. 97-113. In M. S. Campo (ed.), Papillomavirus research: from natural history to vaccines and beyond. Caister Academic Press, Norfolk, England.
47. Suprynowicz, F. A., G. L. Disbrow, E. Krawczyk, V. Simic, K. Lantzky, and R. Schlegel. 2008. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. Oncogene 27:1071-1078.
48. Suprynowicz, F. A., G. L. Disbrow, V. Simic, and R. Schlegel. 2005. Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? Virology 332:102-113.
49. Suzich, J. A., S. J. Ghim, F. J. Palmer-Hill, W. I. White, J. K. Tamura, J. A. Bell, J. A. Newsome, A. B. Jenson, and R. Schlegel. 1995. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92:11553-11557.
50. Takatsuki, A., K. Arima, and G. Tamura. 1971. Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin. J. Antibiot. (Tokyo) 24:215-223.
51. Tjoelker, L. W., C. E. Seyfried, R. L. Eddy, Jr., M. G. Byers, T. B. Shows, J. Calderon, R. B. Schreiber, and P. W. Gray. 1994. Human, mouse, and rat calnexin cDNA cloning: identification of potential calcium binding motifs and gene localization to human chromosome 5. Biochemistry 33:3229-3236.
52. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19. (Pubitemid 29406813)
53. Yaseen, N. R., and G. Blobel. 1997. Cloning and characterization of human karyopherin beta3. Proc. Natl. Acad. Sci. USA 94:4451-4456.
54. Yoshida, H., T. Matsui, A. Yamamoto, T. Okada, and K. Mori. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881-891. (Pubitemid 34084979)
55. Yu, C. Y., Y. W. Hsu, C. L. Liao, and Y. L. Lin. 2006. Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J. Virol. 80:11868-11880.
56. Yuan, H., P. A. Estes, Y. Chen, J. Newsome, V. A. Olcese, R. L. Garcea, and R. Schlegel. 2001. Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J. Virol. 75:7848-7853. (Pubitemid 32743655)
57. Zhang, B., P. Li, E. Wang, Z. Brahmi, K. W. Dunn, J. S. Blum, and A. Roman. 2003. The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology 310:100-108. (Pubitemid 38352585)
58. Zhang, B., A. Srirangam, D. A. Potter, and A. Roman. 2005. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes. Oncogene 24:2585-2588. (Pubitemid 40593050)
59. Zhao, L., and S. L. Ackerman. 2006. Endoplasmic reticulum stress in health and disease. Curr. Opin. Cell Biol. 18:444-452.
60. Zheng, Y., B. Gao, L. Ye, L. Kong, W. Jing, X. Yang, and Z. Wu. 2005. Hepatitis C virus non-structural protein NS4B can modulate an unfolded protein response. J. Microbiol. 43:529-536.
61. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.